[EN] 3' SUBSTITUTED COMPOUNDS HAVING 5-HTCOMPOSÉS SUBSTITUÉS EN POSITION 3' AYANT UNE AFFINITÉ VIS-À-VIS DU RÉCEPTEUR 5-HT620090924US6916818B2EDWARDS LOUISE [CA], et al20050712XXHOLENZ ET AL.: "Medicinal chemistry strategies to 5-HT6 receptor ligands as potential cognitive enhancers and antiobesity agents.", DRUG DISCOVERY TODAY, vol. 11, no. 7-8, April 2006 (2006-04-01), pages 283 - 299, XP025027086HOLENZ ET AL.Medicinal chemistry strategies to 5-HT6 receptor ligands as potential cognitive enhancers and antiobesity agents.DRUG DISCOVERY TODAY200604117-8283299YY [FR] COMPOSÉS SUBSTITUÉS EN POSITION 3' AYANT UNE AFFINITÉ VIS-À-VIS DU RÉCEPTEUR 5-HT6
6' SUBSTITUTED COMPOUNDS HAVING 5-HT6 RECEPTOR AFFINITY
申请人:Dunn Robert
公开号:US20080200471A1
公开(公告)日:2008-08-21
The present disclosure provides compounds having affinity for the 5-HT6 receptor which are of the formula (I):
wherein R
1
—R
4
A, B, D, E, and G are as defined herein. The disclosure also relates to methods of preparing such compounds, compositions containing such compounds, and methods of use thereof.
[EN] CONDENSED HETEROCYCLIC COMPOUNDS HAVING 5-HT6 RECEPTOR AFFINITY<br/>[FR] COMPOSÉS HÉTÉROCYCLIQUES CONDENSÉS AYANT UNE AFFINITÉ POUR LE RÉCEPTEUR 5-HT6
申请人:MEMORY PHARM CORP
公开号:WO2010021797A1
公开(公告)日:2010-02-25
The present disclosure provides compounds having affinity for the 5-HT6 receptor which are of the formula (I) wherein R1, A, B, D, E, G, Q, Ar, n, m, and p are as defined herein. The disclosure also relates to methods of preparing such compounds, compositions containing such compounds, and methods of use thereof.
The present disclosure provides compounds having affinity for the 5-HT
6
receptor which are of the formula (I):
wherein R
1
, R
2
, R
5
, Q, G, Ar, m, and n are as defined herein. The disclosure also relates to methods of preparing such compounds, compositions containing such compounds, and methods of use thereof.
[EN] 4'-AMINO CYCLIC COMPOUNDS HAVING 5-HT6 RECEPTOR AFFINITY<br/>[FR] COMPOSÉS 4'-AMINO CYCLIQUES PRÉSENTANT UNE AFFINITÉ POUR LE RÉCEPTEUR 5-HT6
申请人:MEMORY PHARM CORP
公开号:WO2010024980A1
公开(公告)日:2010-03-04
The present disclosure provides compounds having affinity for the 5-HT6 receptor which are of the formula (I): formula (I) wherein Cy is selected from formula (Il) and wherein R1, R2, R3, Q, G, Ar, m, n and p are as defined herein. The disclosure also relates to methods of preparing such compounds, compositions containing such compounds, and methods of use thereof.
PYRROLIDINE-SUBSTITUTED AZAINDOLE COMPOUNDS HAVING 5-HT6 RECEPTOR AFFINITY
申请人:Danca Mihaela Diana
公开号:US20100022581A1
公开(公告)日:2010-01-28
The present disclosure provides compounds having affinity for the 5-HT
6
receptor which are of the formula (I):
wherein R
1
, R
2
, A, B, D, E, G, Ar, and n are as defined herein. The disclosure also relates to methods of preparing such compounds, compositions containing such compounds, and methods of use thereof.